The biology and rationale of targeting nectin-4 in urothelial carcinoma von Heath, Elisabeth I., Rosenberg, Jonathan E.

Volltext

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy von Rosenberg, Jonathan E, O'Donnell, Peter H, Balar, Arjun V, McGregor, Bradley A, Heath, Elisabeth I, Yu, Evan Y, Galsky, Matthew D, Hahn, Noah M, Gartner, Elaina M, Pinelli, Juan M, Liang, Shang-Ying, Melhem-Bertrandt, Amal, Petrylak, Daniel P

Volltext

Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer von Wu, Yi-Mi, Cieślik, Marcin, Lonigro, Robert J., Vats, Pankaj, Reimers, Melissa A., Cao, Xuhong, Ning, Yu, Wang, Lisha, Kunju, Lakshmi P., de Sarkar, Navonil, Heath, Elisabeth I., Chou, Jonathan, Feng, Felix Y., Nelson, Peter S., de Bono, Johann S., Zou, Weiping, Montgomery, Bruce, Alva, Ajjai, Robinson, Dan R., Chinnaiyan, Arul M.

Volltext

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial von Corn, Paul G, MD, Heath, Elisabeth I, Prof, Zurita, Amado, MD, Ramesh, Naveen, MS, Xiao, Lianchun, MS, Sei, Emi, PhD, Li-Ning-Tapia, Elsa, MD, Tu, Shi-Ming, Prof, Subudhi, Sumit K, MD, Wang, Jennifer, MD, Wang, Xuemei, MS, Efstathiou, Eleni, MD, Thompson, Timothy C, Prof, Troncoso, Patricia, Prof, Navin, Nicholas, PhD, Logothetis, Christopher J, Prof, Aparicio, Ana M, MD

Volltext

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis von Conley-LaComb, M Katie, Semaan, Louie, Singareddy, Rajareddy, Li, Yanfeng, Heath, Elisabeth I, Kim, Seongho, Cher, Michael L, Chinni, Sreenivasa R

Volltext

Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies von Munj, Seeya Awadhut, Taz, Tasnimul Alam, Arslanturk, Suzan, Heath, Elisabeth I

Volltext

A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of c-Met and Vascular Endothelial Growth Factor Receptor 2 von EDER, Joseph Paul, SHAPIRO, Geoffrey I, MCCALLUM, Stewart, HEATH, Elisabeth I, BOERNER, Scott A, LORUSSO, Patricia M, APPLEMAN, Leonard J, ZHU, Andrew X, MILES, Dale, KEER, Harold, CANCILLA, Belinda, CHU, Felix, HITCHCOCK-BRYAN, Suzanne, SHERMAN, Laurie

Volltext

A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer von HEATH, Elisabeth I, HILLMAN, David W, PILI, Roberto, CARDUCCI, Michael A, ERLICHMAN, Charles, LIU, Glenn, VAISHAMPAYAN, Ulka, SHIJIE SHENG, SARKAR, Fazlul, HARPER, Felicity, GASKINS, Melvin, PITOT, Henry C, TAN, Winston, IVY, S. Percy

Volltext

Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer von Heath, Elisabeth I, Heilbrun, Lance K, Smith, Daryn, Schopperle, William M, Ju, Yawen, Bolton, Susan, Ahmed, Quratulain, Sakr, Wael A

Volltext

Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors von LORUSSO, Patricia M, EDELMAN, Martin J, LEAMON, Christopher P, MESSMANN, Richard A, SAUSVILLE, Edward A, BEVER, Susan L, FORMAN, Karen M, PILAT, Maryjo, QUINN, Mary F, JING LI, HEATH, Elisabeth I, MALBURG, Lisa M, KLEIN, Patrick J

Volltext

Prostate Cancer-Specific Lysine 53 Acetylation of Cytochrome c Drives Metabolic Reprogramming and Protects from Apoptosis in Intact Cells von Morse, Paul T, Wan, Junmei, Arroum, Tasnim, Herroon, Mackenzie K, Kalpage, Hasini A, Bazylianska, Viktoriia, Lee, Icksoo, Heath, Elisabeth I, Podgorski, Izabela, Hüttemann, Maik

Volltext

DISCO App: study protocol for a randomized controlled trial to test the effectiveness of a patient intervention to reduce the financial burden of cancer in a diverse patient popula... von Hamel, Lauren M, Dougherty, David W, Kim, Seongho, Heath, Elisabeth I, Mabunda, Lorna, Tadesse, Eyouab, Hill, RaeAnn, Eggly, Susan

Volltext

Angiogenesis inhibitors in the treatment of prostate cancer von Hwang, Clara, Heath, Elisabeth I

Volltext

Prostate cancer dormancy and recurrence von Cackowski, Frank C., Heath, Elisabeth I.

Volltext

Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma von Meagher, Margaret, Krause, Harris, Elliott, Andrew, Farrell, Alex, Antonarakis, Emmanuel S., Bastos, Bruno, Heath, Elisabeth I., Jamieson, Christina, Stewart, Tyler F., Bagrodia, Aditya, Nabhan, Chadi, Oberley, Matt, McKay, Rana R., Salmasi, Amirali

Volltext

Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study von Eggly, Susan, Senft, Nicole, Kim, Seongho, Heath, Elisabeth I, Jang, Hyejeong, Moore, Tanina F, Baidoun, Fatmeh, Manning, Mark A, Penner, Louis A, Albrecht, Terrance L, Carducci, Michael A, Lansey, Dina, Hamel, Lauren M

Volltext

Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas von Coveler, Andrew L, Smith, David C, Phillips, Tycel, Curti, Brendan D, Goel, Sanjay, Mehta, Amitkumar N, Kuzel, Timothy M, Markovic, Svetomir N, Rixe, Olivier, Bajor, David L, Gajewski, Thomas F, Gutierrez, Martin, Lee, Hun Ju, Gopal, Ajay K, Caimi, Paolo, Heath, Elisabeth I, Thompson, John A, Ansari, Sahar, Jacquemont, Celine, Topletz-Erickson, Ariel, Zhou, Peigen, Schmitt, Michael W, Grilley-Olson, Juneko E

Volltext

Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis von Bazylianska, Viktoriia, Kalpage, Hasini A, Wan, Junmei, Vaishnav, Asmita, Mahapatra, Gargi, Turner, Alice A, Chowdhury, Dipanwita Dutta, Kim, Katherine, Morse, Paul T, Lee, Icksoo, Brunzelle, Joseph S, Polin, Lisa, Subedi, Prabal, Heath, Elisabeth I, Podgorski, Izabela, Marcus, Katrin, Edwards, Brian F P, Hüttemann, Maik

Volltext

The impact of high intensity interval training in a diverse group of cancer survivors: CAPABLE, a pilot study von Beebe-Dimmer, Jennifer L., Finlay, David G., Ruterbusch, Julie J., Baird, Tara, Simon, Michael S., Abrams, Judith, Harper, Felicity W.K., Podgorski, Izabela, Heath, Elisabeth I.

Volltext

Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA von Swami, Umang, Zimmerman, Raquel Mae, Nussenzveig, Roberto H, Hernandez, Edgar Javier, Jo, Yeonjung, Sayegh, Nicolas, Wesolowski, Sergiusz, Kiedrowski, Lesli A, Barata, Pedro C, Lemmon, Gordon Howard, Bilen, Mehmet A, Heath, Elisabeth I, Nandagopal, Lakshminarayan, Babiker, Hani M, Pal, Sumanta K, Lilly, Michael, Maughan, Benjamin L, Haaland, Benjamin, Yandell, Mark, Sartor, Oliver, Agarwal, Neeraj

Volltext